Baicheng Pharmaceutical (301096.SZ) released its 2023 annual report. The company's revenue was 1,017 billion yuan,...
According to Zhitong Finance App, Baicheng Pharmaceutical (301096.SZ) released its 2023 annual report. The company's operating income was 1,017 million yuan, up 67.51% year on year; net profit attributable to shareholders of listed companies was 272 million yuan, up 40.07% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 259 million yuan, up 52.48% year on year; basic earnings per share were 2.51 yuan/share. It is proposed to distribute a cash dividend of 3 yuan (tax included) for every 10 shares to all shareholders.